AbbVie | ABBV - Market Capitalization

Stock Price
211.45
Daily Change
-14.21 -6.30%
Monthly
-3.96%
Yearly
10.27%
Q1 Forecast
216.14

AbbVie reported $371.81B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 371.63B 37.4B Feb/2026
Abbott USD 217.86B 15.25B Dec/2025
ALKERMES USD 4.95B 235M Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Eisai JPY 1.45T 280.95B Sep/2025
Eli Lilly USD 1.02T 300.22B Feb/2026
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Medtronic USD 120.14B 1.06B Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025
Zoetis USD 64.85B 4.58B Sep/2025